Karyopharm Therapeutics (KPTI) Total Current Liabilities (2012 - 2026)
Karyopharm Therapeutics' Total Current Liabilities came in at $134.23 million for Q2 2026, up 35.3% from $99.22 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Total Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Total Current Liabilities was $92.06 million, down 0.2% from FY2024.
- Total Current Liabilities carries a five-year compound annual growth rate of 8.9% (FY2020 to FY2025).
- Going back by year, Total Current Liabilities was $92.26 million in FY2024 (+32.8%), $69.48 million in FY2023 (+5.4%), $65.91 million in FY2022 (-10.6%) and $73.72 million in FY2021 (+22.4%).
- The Q2 2026 figure represents the highest quarterly Total Current Liabilities in data going back to Q4 2012.
- Year-over-year, Total Current Liabilities increased in five of the last seven quarters, with growth averaging 31.3%.
- The fastest year-over-year change in Total Current Liabilities over five years came in Q2 2025 (growth of 72.2%), and the weakest in Q4 2022 (a decline of 10.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Karyopharm Therapeutics | 11.50 Mn | -214.92 Mn | 32.35 Mn | 134.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134.23 Mn |
| Dec 31, 2025 | 92.06 Mn |
| Sep 30, 2025 | 87.16 Mn |
| Jun 30, 2025 | 99.22 Mn |
| Mar 31, 2025 | 90.37 Mn |
| Dec 31, 2024 | 92.26 Mn |
| Sep 30, 2024 | 61.49 Mn |
| Jun 30, 2024 | 57.62 Mn |
| Mar 31, 2024 | 65.34 Mn |
| Dec 31, 2023 | 69.48 Mn |
| Sep 30, 2023 | 62.08 Mn |
| Jun 30, 2023 | 58.93 Mn |
| Mar 31, 2023 | 61.56 Mn |
| Dec 31, 2022 | 65.91 Mn |
| Sep 30, 2022 | 61.76 Mn |
| Jun 30, 2022 | 62.54 Mn |
| Mar 31, 2022 | 66.34 Mn |
| Dec 31, 2021 | 73.72 Mn |
| Sep 30, 2021 | 68.87 Mn |
| Jun 30, 2021 | 58.12 Mn |
API Access
Karyopharm Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();